| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018269 |
| Receipt No. | R000021140 |
| Official scientific title of the study | A study to evaluate the effect of decreasing serum uric acid level by ingestion of botanical ingredient-containing foods |
| Date of disclosure of the study information | 2015/07/13 |
| Last modified on | 2016/07/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A study to evaluate the effect of decreasing serum uric acid level by ingestion of botanical ingredient-containing foods | |
| Title of the study (Brief title) | A study to evaluate the effect of decreasing serum uric acid level by ingestion of botanical ingredient-containing foods | |
| Region |
|
|
| Condition | ||
| Condition | hyperuricemia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of decreasing serum uric acid level and safety by ingestion of botanical ingredient-containing foods |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Serum uric acid level |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Botanical ingredient-containing foods, 12 Weeks | |
| Interventions/Control_2 | Botanical ingredient-free foods, 12 Weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) 20 years of age or older
2) 6.0 mg/dL <= serum uric acid level < 9.0 mg/dL 3) With no treatment. 4) Submitting the written informed consent before this study. |
|||
| Key exclusion criteria | 1) With gouty arthritis and gouty arthritis.
2) With high serum uric acid level (>= 8.0 mg/dL) and kidney damage, urinary stone, hypertension, ischemic cardiac disease, diabetes, metabolic syndrome. 3) Use of product affecting the data of this study, such as medicine, food for specified health use, supplement, diet food. 4) Female in pregnancy, lactation and scheduled pregnancy period. 5) Investigator's judgment for other reason. |
|||
| Target sample size | 75 | |||
| Research contact person | |
| Name of lead principal investigator | Junichi Nakamura |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0460 |
| Junichi_Nakamura@suntory.co.jp | |
| Public contact | |
| Name of contact person | Hidenori Obata |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0568 |
| Homepage URL | |
| Hidenori_Obata@suntory.co.jp | |
| Sponsor | |
| Institute | New Drug Research Center, Inc. |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Suntory Beer Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021140 |